1. Home
  2. CINGW vs GCMGW Comparison

CINGW vs GCMGW Comparison

Compare CINGW & GCMGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CINGW
  • GCMGW
  • Stock Information
  • Founded
  • CINGW N/A
  • GCMGW 1971
  • Country
  • CINGW United States
  • GCMGW United States
  • Employees
  • CINGW 13
  • GCMGW N/A
  • Industry
  • CINGW Biotechnology: Pharmaceutical Preparations
  • GCMGW Finance/Investors Services
  • Sector
  • CINGW Health Care
  • GCMGW Finance
  • Exchange
  • CINGW Nasdaq
  • GCMGW Nasdaq
  • Market Cap
  • CINGW N/A
  • GCMGW N/A
  • IPO Year
  • CINGW 2021
  • GCMGW N/A
  • Fundamental
  • Price
  • CINGW $0.04
  • GCMGW $2.24
  • Analyst Decision
  • CINGW
  • GCMGW
  • Analyst Count
  • CINGW 0
  • GCMGW 0
  • Target Price
  • CINGW N/A
  • GCMGW N/A
  • AVG Volume (30 Days)
  • CINGW N/A
  • GCMGW 60.0K
  • Earning Date
  • CINGW N/A
  • GCMGW 02-13-2025
  • Dividend Yield
  • CINGW N/A
  • GCMGW N/A
  • EPS Growth
  • CINGW N/A
  • GCMGW N/A
  • EPS
  • CINGW N/A
  • GCMGW 0.03
  • Revenue
  • CINGW N/A
  • GCMGW $514,011,999.00
  • Revenue This Year
  • CINGW N/A
  • GCMGW N/A
  • Revenue Next Year
  • CINGW N/A
  • GCMGW N/A
  • P/E Ratio
  • CINGW N/A
  • GCMGW $32.95
  • Revenue Growth
  • CINGW N/A
  • GCMGW 15.79
  • 52 Week Low
  • CINGW N/A
  • GCMGW $2.25
  • 52 Week High
  • CINGW N/A
  • GCMGW $2.35
  • Technical
  • Relative Strength Index (RSI)
  • CINGW N/A
  • GCMGW N/A
  • Support Level
  • CINGW N/A
  • GCMGW N/A
  • Resistance Level
  • CINGW N/A
  • GCMGW N/A
  • Average True Range (ATR)
  • CINGW 0.00
  • GCMGW 0.00
  • MACD
  • CINGW 0.00
  • GCMGW 0.00
  • Stochastic Oscillator
  • CINGW 0.00
  • GCMGW 0.00

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About GCMGW GCM Grosvenor Inc.

GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.

Share on Social Networks: